⌘K

Home/Filings/4/0001209191-22-000954

4//SEC Filing

Harsh Michael 4

Accession 0001209191-22-000954

CIK 0001681682other

View on SEC.gov Company Profile

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 5:05 PM ET

Size

5.4 KB

Accession

0001209191-22-000954

Insider Transaction Report

Form 4

Period: 2022-01-03

ENDRA Life Sciences Inc.NDRA

Director

Transactions

Award
Stock Options
2022-01-03+12,000→ 12,000 total
Exercise: $0.74From: 2023-01-03Exp: 2032-01-03→ Common Stock (12,000 underlying)

Footnotes (1)

[F1]Represents a stock option award granted on January 3, 2022 pursuant to the Issuer's Non-Employee Director Compensation Policy.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1

filerCIK 0001706155

Filing Metadata

Form type: 4
Filed: Jan 3, 7:00 PM ET
Accepted: Jan 4, 5:05 PM ET
Size: 5.4 KB

View on SEC.gov